Evoke Pharma Prices IPO Of 2.10 Mln Common Shares At $12 A Share

(RTTNews) - Evoke Pharma, Inc. (EVOK) announced the pricing of its initial public offering or IPO of 2.10 million shares of its common stock at a public offering price of $12.00 per share.

The company said the gross proceeds to Evoke Pharma from the initial public offering are expected to be $25.2 million before underwriting discounts and commissions and estimated offering expenses. Evoke has granted the representative of the underwriters a 30 day option to purchase up to 315,000 additional shares of common stock from the company to cover over-allotments, if any.

The offering is expected to close on September 30, 2013, subject to customary closing conditions.